ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors.

Rafal Zielinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.